Explore
Validate
LearnAP16101PU-T
antibody from Acris Antibodies GmbH
Targeting: TRIM28
KAP1, PPP1R157, RNF96, TF1B, TIF1B
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AP16101PU-T - Provider product page
- Provider
- Acris Antibodies GmbH
- Proper citation
- Acris Antibodies GmbH Cat#AP16101PU-T, RRID:AB_10978360
- Product name
- anti TIF1-beta / TRIM28 (C-term)
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide from the C-Terminus sequence according to NP_005753.1
- Reactivity
- Human, Mouse
- Host
- Goat
- Vial size
- 20 µg
- Concentration
- 0.5 mg/ml
Submitted references KAP1 is associated with peritoneal carcinomatosis in gastric cancer.
Yokoe T, Toiyama Y, Okugawa Y, Tanaka K, Ohi M, Inoue Y, Mohri Y, Miki C, Kusunoki M
Annals of surgical oncology 2010 Mar;17(3):821-8
Annals of surgical oncology 2010 Mar;17(3):821-8
No comments: Submit comment
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- AP16101PU-N TRIM28 Antibody staining of HepG2 lysate at 2.0 µg/ml (35µg protein in RIPA buffer). Primary incubated for 1 hour. Detected by western blot using chemiluminescence.
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- AP16101PU-N TRIM28 Antibody staining of Paraffin Embedded Human Breast at 4 µg/ml. Steamed antigen retrieval with citrate buffer pH 6, HRP-staining.
